Best of intent, worst of both worlds: why sequentially combining epidemiological designs does not improve signal detection in vaccine safety surveillance
Arshad, F.; Schuemie, M. J.; Minty, E. P.; Alshammari, T. M.; Lai, L. Y.; Duarte-Salles, T.; Fortin, S.; Nyberg, F.; Ryan, P. B.; Hripcsak, G.; Prieto-Alhambra, D.; Suchard, M. A.
Show abstract
BackgroundVaccine safety surveillance commonly includes a serial testing approach with a sensitive method for "signal generation" and specific method for "signal validation." Whether serially combining epidemiological designs improves both sensitivity and specificity is unknown. MethodsWe assessed the overall performance of serial testing using three administrative claims and one electronic health record database. We compared Type I and II errors before and after empirical calibration for historical comparator, SCCS, and the serial combination of those designs against six vaccine exposure groups with 93 negative control and 279 imputed positive control outcomes. ResultsHistorical comparator mostly had lower Type II error than SCCS. SCCS had lower Type I error than the historical comparator. Before empirical calibration, serial combination increased specificity and decreased sensitivity. Type II errors mostly exceeded 50%. After empirical calibration, Type I errors returned to nominal; sensitivity was lowest when the methods were combined. ConclusionWe recommend against the serial approach in vaccine safety surveillance. While serial combination produced fewer false positive signals compared to the most specific method, it generated more false negative signals compared to the most sensitive method. Using the noisy historical comparator in front of SCCS deteriorated overall performance in evaluating safety signals. Key MessagesO_LIUsing the serial approach in vaccine safety surveillance did not improve overall performance: specificity increased but sensitivity decreased. C_LIO_LIWithout empirical calibration, Type II errors exceeded 50%; after empirical calibration, Type I error rates returned to nominal with negligible change to Type II error rates. C_LIO_LIWhile prior research has suggested high sensitivity of the historical comparator method in distinguishing true safety signals, there were cases when self-controlled case series was more sensitive. C_LIO_LIVaccine safety surveillance is becoming increasingly important, so monitoring systems should closely consider the utility and sequence of epidemiological designs. C_LI
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and Myocarditis using Five European Databases 95%
- Agreement between state registry, health record, and self-report of influenza vaccination 95%
- Safety Monitoring of Health Outcomes following Influenza Vaccination during the 2023-2024 Season among U.S. Medicare Beneficiaries Aged 65 Years and Older 94%
Similar papers in this journal
- Exploring the Application of Target Trial Emulation in Vaccine Evaluation: Scoping Review 94%
- Estimating protection afforded by prior infection in preventing reinfection: Applying the test-negative study design 94%
- Magnitude of Potential Biases in COVID-19 Vaccine Effectiveness Studies due to Differential Healthcare seeking following Home Testing: Implications for Test Negative Design Studies 93%
Similar papers in this journal
- Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study 93%
- Factors indicating intention to vaccinate with a COVID-19 vaccine among older U.S. Adults 93%
- Predicting Clinical Outcomes of SARS-CoV-2 Infection During the Omicron Wave Using Machine Learning 93%
Similar papers in this journal
- Safety Monitoring of Bivalent COVID-19 mRNA Vaccines Among Recipients 6 months and Older in the United States 94%
- Risk of Myopericarditis following COVID-19 mRNA vaccination in a Large Integrated Health System: A Comparison of Completeness and Timeliness of Two Methods 91%
- Safety of BNT162b2 mRNA COVID-19 vaccine batches: A nationwide cohort study 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.